[Ensure treatment for IUGR].
Copyright policy )[Ensure treatment for IUGR].
A prospective study on Ensure and amino acid infusion treatment for IUGR was carried out in 1989 and 1990 in PUMC Hospital. The patients were divided into two groups. Subjects in group 1 received Ensure, and those in group 2 received amino acid treatment. Each group included 40 subjects. The incidence of SGA was found to decrease from 2.18% in 1989 to 1.59% in 1990. The cure rate of IUGR reached 41.7% and 21.9% in groups 1 and 2, respectively. The average birth weights were 2,820g and 2,656g in groups 1 and 2 (t = 19.15, P < 0.001), respectively. Our conclusion is that Ensure is an effective nutritional drug for treatment of IUGR.
Food, Formulated, Fetal Growth Retardation, Carbohydrates, Infant, Newborn, Dietary Sucrose, Pregnancy, Infant, Small for Gestational Age, Birth Weight, Humans, Female, Prospective Studies
Food, Formulated, Fetal Growth Retardation, Carbohydrates, Infant, Newborn, Dietary Sucrose, Pregnancy, Infant, Small for Gestational Age, Birth Weight, Humans, Female, Prospective Studies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!